Treatment of osteosarcoma cells with CX-5461, a G4 ligand, lead to induction of autophagic cell death caused by MTOR inhibition, activation of AMPK pathway and increased levels of p53, SESN1, SESN2 and CDKN1A53. This evidence concerns the gene TP53 and osteosarcoma.